RAFFA WEALTH MANAGEMENT, LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
BTW
ETC
AL
SGH
PFSRSONJ
FISPB
AB
RAFFA WEALTH MANAGEMENT, LLC's BIO Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Bio-Rad Laboratories Class A (BIO) stake by 20% in Q2 2026, buying an estimated $284 and bringing the position to 6 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #870.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in BIO in Q1 2018 and has held it in 33 quarters since. The position peaked at $8.45K in Q2 2025. 93 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 6 shares of Bio-Rad Laboratories Class A worth $1.76K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
- Bio-Rad Laboratories Class A made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #870 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 33 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Bio-Rad Laboratories Class A position peaked at $8.45K in Q2 2025.
- 93 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.